User profiles for Luanne M. Metz

Luanne Marie Metz

University of Calgary
Verified email at ahs.ca
Cited by 19240

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

…, L Kappos, FD Lublin, LM Metz… - Annals of Neurology …, 2005 - Wiley Online Library
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image
assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald …

The promise of minocycline in neurology

…, F Giuliani, S Casha, C Power, LM Metz - The Lancet …, 2004 - thelancet.com
The capacity of minocycline to alleviate disease for several neurological disorders in animals
is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of …

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

V Brundula, NB Rewcastle, LM Metz, CC Bernard… - Brain, 2002 - academic.oup.com
Multiple sclerosis is characterized by the infiltration of leukocytes into the CNS. As matrix
metalloproteinases (MMPs) facilitate the passage of leukocytes across matrix barriers, we …

Long-term medical conditions and major depression: strength of association for specific conditions in the general population

…, JVA Williams, C Barbui, LM Metz - The Canadian …, 2005 - journals.sagepub.com
Background: The prevalence of major depression (MD) in persons with nonpsychiatric medical
conditions is an indicator of clinical need in those groups, an indicator of the feasibility of …

Regional variation of multiple sclerosis prevalence in Canada

CA Beck, LM Metz, LW Svenson… - Multiple Sclerosis …, 2005 - journals.sagepub.com
Objective: To describe the regional distribution of multiple sclerosis (MS) prevalence in
Canada, controlling for age and sex. Methods: This study used data from the Canadian …

[HTML][HTML] Trial of minocycline in a clinically isolated syndrome of multiple sclerosis

LM Metz, DKB Li, AL Traboulsee… - … England Journal of …, 2017 - Mass Medical Soc
Background On the basis of encouraging preliminary results, we conducted a randomized,
controlled trial to determine whether minocycline reduces the risk of conversion from a first …

Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population

SB Patten, LM Metz, MA Reimer - Multiple Sclerosis Journal, 2000 - journals.sagepub.com
The objective of this paper was to evaluate the lifetime and point prevalence of major
depression in a population-based Multiple Sclerosis (MS) clinic sample, and to describe …

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

…, RK Zabad, S Agrawal, AG DaSilva, LM Metz - Journal of the …, 2007 - Elsevier
The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS).
This review summarizes the consequences of upregulation of MMP members in MS as …

[PDF][PDF] Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

LM Metz, Y Zhang, M Yeung, DG Patry, RB Bell… - Annals of …, 2004 - unfictional.com
We report a trial of minocycline in people with relapsingremitting multiple sclerosis (RRMS)
that evaluates safety and estimates its effect on magnetic resonance imaging (MRI). Ten …

Epigenetic changes in patients with multiple sclerosis

MW Koch, LM Metz, O Kovalchuk - Nature Reviews Neurology, 2013 - nature.com
Epigenetic changes influence gene expression without altering the DNA sequence. DNA
methylation, histone modification and microRNA-associated post-transcriptional gene silencing …